EPISTAXIS

Clinical trials for EPISTAXIS explained in plain language.

Never miss a new study

Get alerted when new EPISTAXIS trials appear

Sign up with your email to follow new studies for EPISTAXIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

New hope for controlling debilitating nosebleeds in rare disease

Disease control Ongoing

This study is testing whether a drug called pazopanib can help people with hereditary hemorrhagic telangiectasia (HHT), a genetic disorder that causes frequent, severe nosebleeds and anemia. About 70 participants will take either pazopanib or a placebo pill daily for 24 weeks to …

Matched conditions: EPISTAXIS

Phase: PHASE2, PHASE3 • Sponsor: Cure HHT • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

EPISTAXIS

Get alerted when new EPISTAXIS trials appear

New hope for controlling debilitating nosebleeds in rare disease